chrisvoncsefalvay/vaers-outcomes huggingface dataset:
atrial fib; palpitaions; high blood pressure; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 82 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Jan2022 12:00 (Lot number: FD7218) at the age of 82 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Prev dose product=COVID 19, Prev dose brand=Pfizer, brand unknown=False,, lot number: EL9262,, lot unknown=False,, administration time: 01:00 PM , number=1, vaccine location=Left arm), administration date: 25Jan2021, when the patient was 81 years old, for Covid-19 immunization; Bnt162b2 (product=COVID 19, brand=Pfizer, brand unknown=False,, lot number: EN6201,, lot unknown: False, dose administration time: 02:00 PM, dose number=2, dose vaccine location=Left arm), administration date: 11Feb2021, when the patient was 81 years old, for Covid-19 immunization, reaction(s): "atrial fib", "high blood pressure", "Palpitations". The following information was reported: ATRIAL FIBRILLATION (disability) with onset 23Jan2022 16:00, outcome "recovered with sequelae", described as "atrial fib"; PALPITATIONS (disability) with onset 23Jan2022 16:00, outcome "recovered with sequelae", described as "palpitaions"; HYPERTENSION (disability) with onset 23Jan2022 16:00, outcome "recovered with sequelae", described as "high blood pressure". The patient underwent the following laboratory tests and procedures: blood pressure measurement: (23Jan2022) high. Therapeutic measures were not taken as a result of atrial fibrillation, palpitations, hypertension.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine cannot be excluded for the reported events due to temporal relationship.
hyperhydrosis and palpitations that started about 3 days after the last dose of covid vaccine and symptoms still ongoing.
On 2/19/2021 I started getting a rash hand. It work its way up to the elbow. Then it started to appear also on my right arm. It was very itchy, burning sensation, & very red. It looked like scabies but it was not that. I followed up with my doctor and he prescribed me Hydrotoxin & prednisone. Also had a little bit of nausea.
Started with a little itchy bump which she started getting on her face and all over her. It comes and goes and itch real bad. Went to the dr and they prescribed her methylprednisolone  and she also takes Benadryl. She also to the ER and urgent care
No AE; she received late shipment on 8/7/2023 and should have been received on 8/6/2023 of VARIVAX and MMR II. Spoke with HCP who informed VARIVAX was given to 5patients; she received late shipment on 8/7/2023 and should have been received on 8/6/2023 of VARIVAX and MMR II. Spoke with HCP who informed VARIVAX was given to 5patients; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  Healthcare provided (HCP) stated she received late shipment on 07-AUG-2023 and should have been received on 06-AUG-2023 of varicella virus vaccine live (OKA/MERCK) (VARIVAX) (Product distribution issue). On 10-AUG-2023, the patient was vaccinated with an improperly storage varicella virus vaccine live (OKA/MERCK) (VARIVAX) subcutaneous injection, 0.5 milliliter/x1, lot #X010525, expiration date: 11-APR-2025, administered for prophylaxis (strength, and route of administration were not provided) (Product storage error). No additional adverse event was reported.
pt admitted to hosp with generalized weakness, cachectic, positive for COVID, emaciated, wt 32kg, placed on O2; steroids, ABX; pt's condition worsened and she passed away peacefully in the hospital
The shot was painful, felt flu like the next day which I expected. However, I still feel a tingling at the injection site, slight itch, and soreness.
Numbness and tingling in 4th and 5th digit starting after vaccine was administered in 2014. Symptoms are still present.
Contact was sick during this study; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (Contact was sick during this study) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccine. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 vaccine.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Contact was sick during this study). At the time of the report, ILLNESS (Contact was sick during this study) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Extremely painful swollen lymph nodes in right arm pit and extending down to side of right breast.
Left shoulder pain after HPV vaccine. Reports did not have pain immediately after vaccine. Pain started 2-3 days after. Pain makes it hard to sleep and do movement. Pt states did not lift anything or do anything that could have made it worse.  Pt denies swelling or feeling hot. Pt states no discoloration.  Pt denies headache, fever, or other types of body aches.
This is a spontaneous report from a contactable physician. This Physician reported similar events for fifteen patients. This is second of fifteen reports.  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration on an unspecified date as dose 1, 1.3 mL, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, 15 persons received vaccine from vials that has been reconstituted with 1.3 ml instead of 1.8 ml on an unspecified date, they reported significant body aches, nausea, vomiting, diarrhea on an unspecified date. The outcome of the events was unknown at the time of report. Follow-up attempts are completed. Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021189080 Same reporter/drug/event, different patient;US-PFIZER INC-2021189081 Same reporter/drug/event, different patient;US-PFIZER INC-2021189079 Same reporter/drug/event, different patient;US-PFIZER INC-2021189076 Same reporter/drug/event, different patient;US-PFIZER INC-2021189073 Same reporter/drug/event, different patient.;US-PFIZER INC-2021189078 Same reporter/drug/event, different patient;US-PFIZER INC-2021189074 Same reporter/drug/event, different patient.;US-PFIZER INC-2021189071 Same reporter/drug/event, different patient.;US-PFIZER INC-2021189072 Same reporter/drug/event, different patient.;US-PFIZER INC-2021189075 Same reporter/drug/event, different patient;US-PFIZER INC-2021189077 Same reporter/drug/event, different patient;US-PFIZER INC-2021189069 Same reporter/drug/event, different patient.;US-PFIZER INC-2021189070 Same reporter/drug/event, different patient.
Dried out lips; Nose got very dry; sore on the outside and a scab would form both nostrils; anywhere with mucous membranes would be dry; Sick for a week; sore on the outside and a scab would form both nostrils; This spontaneous case was reported by a consumer and describes the occurrence of LIP DRY (Dried out lips), NASAL DRYNESS (Nose got very dry), SCAB (sore on the outside and a scab would form both nostrils), MUCOSAL DRYNESS (anywhere with mucous membranes would be dry) and ILLNESS (Sick for a week) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL, ATENOLOL, OXYCODONE, TIZANIDINE, ONE A DAY WOMEN'S, VACCINIUM MACROCARPON (CRANBERRY CONCENTRATE [VACCINIUM MACROCARPON]), ACETYLSALICYLIC ACID (BABY ASPIRIN) and FISH OIL for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced LIP DRY (Dried out lips), NASAL DRYNESS (Nose got very dry), SCAB (sore on the outside and a scab would form both nostrils), MUCOSAL DRYNESS (anywhere with mucous membranes would be dry) and ILLNESS (Sick for a week). March 2021, the patient experienced NASAL DISCOMFORT (sore on the outside and a scab would form both nostrils). The patient was treated with PARAFFIN (VASELINE [PARAFFIN]) in March 2021 at an unspecified dose and frequency. In April 2021, ILLNESS (Sick for a week) had resolved. At the time of the report, LIP DRY (Dried out lips), NASAL DRYNESS (Nose got very dry), SCAB (sore on the outside and a scab would form both nostrils), MUCOSAL DRYNESS (anywhere with mucous membranes would be dry) and NASAL DISCOMFORT (sore on the outside and a scab would form both nostrils) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       About 3 days after the first dose the patient experienced adverse events which lasted for about a week. Treatment received included vaseline, lip balm, medicated lip balm.   This case was linked to MOD-2022-470487 (Patient Link).
No adverse events-found out after vaccines were administered patient had already received a dose of Janssen COVID vaccine
Imm. given 8.9.13 - Abd pain/vomiting with increased Eosinophil off on starting 8.10.13. No other Sx. Extensive work up done - Normal. Admitted on 16th as progressed to dehydration. Was mildly acidotic no diagnosis could be made.
Nausea; Fatigue; Arm soreness; This is a spontaneous report received from a contactable reporter (Pharmacist). The reporter is the patient.  A 43-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 43 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 25Sep2022, outcome "unknown", described as "Arm soreness"; FATIGUE (non-serious) with onset 25Sep2022, outcome "unknown"; NAUSEA (non-serious) with onset 25Sep2022, outcome "unknown".  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
FEVER, VOMITING X 1 AND GENERALIZED ITCHING STARTED ON THIRD DAY AFTER VACCINATION
I tested positive for COVID-19 on August 26, 2022. I had a runny nose and sore throat. I went into the Urgent care that same day and took a PCR COVID-19 test and it came back positive. They prescribe me 6 packs of Paxlovid. I did not take the Paxlovid. Felt much better on day three and by the end of the week, I was back to normal.
sx appeared 48hr later;10cm red, swollen area lt deltoid;h/a, felt stiff jaw, arm & shoulder 5-7 days,T98.6;
Well appearing 2 month old infant given immunization at wellness visit. Apparently expired during sleep about 24 hours later.
+fever 103 ax, vomiting x 2, cough, nasal congestion, stuffy nose p/vax;
Symptoms began approx. 45 min after shot. Pain pressure traveled slowly from injection site up neck and into head, down neck and eventually down spine to lower back. Very loud gut noises for 2 hours. Around midnight, the days of injection, 4/2/21, I began feeling intense single bug bite sensations in lower arms and legs. This progressed over the course of hours to all over pins and needles, followed by intense stinging as if being bitten by fire ants, but not sign of rash or redness, followed by numbness, all taking place in lower arms and legs. About 2 am 4/3/21, agitation and restlessness, numbness in lower arms and legs, lasting several hours. Also, slight hand tremor and muscle spasms in lower arms and legs. Alternating cold and hot, but no fever, including sweating. 4/4 /21 at 8 am raised rash on chest. 4/5/21 8 am, rash spreading over more area of chest and becoming darker and more raised. 4/5/21 5 pm, rash improving and not as red, but still itching. 4/3/21 Difficulty breathing and swallowing as if something constricting or lodged in throat lasted a few hours.
swelling and hottness and redness on left arm where 2 vaccines were given at same time..flu and pneumovax. pt has also felt flu like and very sick/unwell. advised her to immediately see her pcp, may be cellulitis
Macular papular rash - resolved after 10-15 min after BENADRYL.
Shingrix - Second dose at Less than Minimum Interval; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 78-year-old female patient who received Herpes zoster (Shingrix) (batch number YC5Y7, expiry date 25-OCT-2024) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 12-JUN-2023, the patient received the 2nd dose of Shingrix. On 12-JUN-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: Shingrix - Second dose at Less than Minimum Interval). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 12-Jun-2023 A pharmacist called in to report the administration of the second dose of Shingrix at less than minimum interval. The reporter asked how to proceed with patient vaccination. During the call permission for follow up was not requested. The patient received second dose of Shingrix earlier than the recommended interval, which led to shortening of vaccine schedule.
Unable to create wheel on first try, administered a second time on left forearm and wheel was successfully create.
Unable to lift her arm at all/I cannot lift arm without screaming; Its more than just pain at the injection site; A spontaneous report (United States) was received from a healthcare professional concerning a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) experienced unable to lift her arm at all/I cannot lift arm without screaming and its more than just pain at the injection site.  The patient's medical history was not provided. No concomitant medications were reported.  On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection.   On 30 Dec 2020, the patient experienced unable to lift her arm at all/I cannot lift arm without screaming and its more than just pain at the injection site. No treatment information was reported.  The action taken with mRNA-1273 in response to the events was unknown.  The outcome for the events, unable to lift her arm at all/I cannot lift arm without screaming and its more than just pain at the injection site was considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I was fine for a  day and a half, little sore in the arm but not much. During the 2nd night I got violently ill throwing up , aches, headache and diarreaha. My vomit was dark color, almost back and my diarreha was so stinky I threw up from briefly smelling it. I have been tired since.
Within hours of my Covid booster vaccine, I had severe pain in my left shoulder and could not move my left arm at all without excruciating pain.  I took Tylenol and iced my shoulder when I got home from work with no results. I did not sleep well because of sharp pain. I called my PCP the next day and since he couldn't see me, his nurse suggested I go to urgent care, which I did. The physician examined me and took an x-ray, which she said showed no results. I still could not move or lift my shoulder or grab with my hand. My wife had to dress me. I was told to take ibuprofin. I cannot drive a car or work and am losing wages.
rapid heartbeat; blood pressure rising; she did take the first shot and her allergies were not as bad; This is a spontaneous report from a contactable consumer (patient herself).  An 85-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0153, Expiry date was not reported), via an unspecified route, administered in left arm on 20Apr2021 at 11:00 (Age at vaccination 85-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The vaccination facility type was pharmacy or drug store. Medical history included asthma (asthma was bad this year since the beginning of Jan2021) to an unknown date and arthritis from an unknown date and unknown if ongoing. Concomitant medications included prednisone ongoing, been taking for maybe 4 or 5 years for asthma and arthritis, formoterol fumarate (SYMBICORT) taken for asthma, start and stop date were not reported. The patient experienced rapid heartbeat, blood pressure rising on 20Apr2021, and she did take the first shot and her allergies were not as bad on an unspecified date in Apr2021. It was reported that she did take the first shot and her allergies were not as bad. The asthma did not get bad because of the vaccine. The asthma had been bad this year since the beginning of January. Patient stated that the symptom she experienced was a rapid heartbeat. She had a thing that she puts her finger in and her heart rate went over 100 and it was about 110. Her blood pressure was rising on 20Apr2021 and so she took an extra half of blood pressure medication, and she took a medication called Librium that she takes for her nerves, 2 pills that were 5mg each and so her heart racing only lasted an hour in a half and she laid down and it subsided. Rapid heartbeat started about an hour after she got home and once it went away which it lasted about hour in a half and was annoying and scary, but it finally went away after she laid down and took medicine. she felt was relevant to the blood pressure that was rising and rapid heartbeat she experienced after receiving the COVID 19 vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received treatment for rapid heartbeat and blood pressure rising. The clinical outcome of the event she did take the first shot and her allergies were not as bad was unknown and rest of the events was resolved on 20Apr2021.  No follow-up attempts are needed. No further information is expected.
A 23 year old female patient experienced flu like symptoms that included fever, chills, muscle aches, headaches, and fatigue while being treated with RabAvert prophylactically for travel to a high risk area. RabAvert was administered on 09/07/2004 and 09/14/2004. Past medical history was unspecified. Concomitant medications included a yellow fever vaccine and a polio vaccine. The patient experienced a fever lasting one day, chills, muscle aches, and a headache an unspecified time period following the first RabAvert vaccine on 09/07/2004. Yellow Fever and Polio vaccines were also administered on 09/07/2004. Reportedly,  some time following the second RabAvert vaccine on 09/14/2004 she experienced fever, chills, fatigue, headache, and body aches which necessitated her going to bed for 36 hours. The nurse did not administer the third dose of RabAvert due on 09/28/2004. The patient had completey recovered at the time of the report.
End of menopause hot flashes days after dose and return on menstrual cycle after 8 months, cycle to date has been 25 days in length and heavy
This spontaneous report was received from a Nurse Practitioner referring to a 42 year old male patient. No information was provided regarding the patient's medical history, previous drug reactions, allergies, concurrent conditions or concomitant medications. On an unspecified date in July 2017 (reported as "13 months go"), the patient was vaccinated with the first dose of GARDASIL 9 for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported); then, on 01-AUG-2018, the patient received the second dose of GARDASIL 9 lot number N028567 with expiration date on 17-MAY-2020, for prophylaxis (dose, route and anatomical location were unknown).
Pain at the injection site, fatigue, chills, body aches, nausea, loss of appetite, low-grade fever (99.6). Pain in my arm and fatigue started about 4 hours after the injection and the rest i woke up with the following morning.
The patient's left thigh was swollen and red, which is the injection site. The patient had a slight fever. The patient has recovered.
Viral URI sx's with clear rhinorrhea and fever. Developed hyperpyrexia with resultant complex febrile seizure. PICU admit x 2 days. Developed viral rash on 5/2/2011.
Pain,swelling,  and redness at injection site.  Also developed a fever low-grade 99.1.  Diagnosed with cellulitis and treated with keflex 500mg tid X7days.
Information has been received from a nurse referring to multiple unspecified patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. This nurse noted that on multiple unspecified dates, multiple unspecified patients were administered with improperly stored PROQUAD (Merck) (lot # L044058, expiration date 02-MAY-2017, dose and frequency not provided) (incorrect storage of drug). The vaccines was stored at 29 Fahrenheit (F) for 4 hours. There was no previous temperature excursion. No adverse effect was reported. This is one of two reports received from the same reporter. Additional information has been requested.
Developed "itchy bumps" at vaccination site, then 2" x 2" firm red hardened area.  Physician prescribed antibiotic per patient.
This spontaneous report as received from a healthcare worker refers to a child. The patient was vaccinated with a dose of MMR II (lot# not reported) and expired sterile diluent (lot# G001274, exp May 2012) on approximately 15-AUG-2012 ("within the past week"). No adverse effects were reported. The reporter stated that the MMR II lot was not expired, just the sterile diluent. It was unknown if the patient sought medical attention. Additional information is not expected.
10:45am patient became unconscious and was laid on the floor with legs elevated.  Heartrate 50 BP 76/60 10:50am BP systolic 90 HR 60 weakly responsive 10:52am BP systolic 92 10:55am More responsive, eyes open, speaking, HR 64, BP systolic 100. 10:58am EMS arrived, patient declined transport.
Given pneumonia shot and had serious allergic reaction. Doctor could not tell me what was in injection.
Classic shingles developed on 11/10/10, 2 1/2 months after varicella vaccine given.